Hamburger A W, White C P, Dunn F E, Citron M L, Hummel S
Int J Cell Cloning. 1983 Sep;1(4):216-29. doi: 10.1002/stem.5530010403.
The factors controlling the growth of human tumor cells in soft agar are poorly understood. However, it has been demonstrated that serum provides factors which promote anchorage-independent growth. We tested 58 tumor specimens, which were obtained from patients with adenocarcinoma of the lung, colon, ovary or squamous cell carcinoma, for their ability to form colonies in soft agar in serum-free or serum-supplemented media. The cells were unable to replicate, and none of the hormones or growth factors tested: insulin (I), transferrin (T), selenium (S), estradiol (E), hydrocortisone (H) or epidermal growth factor (EGF) could substitute for serum. Examination of the serum dose-response curves indicated that growth factors reduced the serum concentrations needed to support anchorage-independent growth. The addition of the supplements and the lowering of serum concentrations increased cloning efficiencies (C.E.) in 38/51 trials, when cells were able to grow initially. The addition of ITS increased C.E. in 18/21 cases, HITES in 15/17 cases and EGF in 12/18 cases as compared to controls. ITS and HITES increased the number of colonies only when serum was the limiting factor. EGF, however, increased the number of colonies even when serum was not the limiting factor. The ability of the supplements to enhance growth could not be correlated to tumor type or initial cloning efficiencies. However, in only 1/25 cases were cells that were unable to form colonies under standard conditions induced to form colonies in the presence of the growth factors. Normal and tumor-derived human fibroblasts did not form colonies in soft agar in the presence of these growth factors. The results suggest that human tumor cells may require the presence of serum-derived factors for growth in soft agar.
目前对控制人类肿瘤细胞在软琼脂中生长的因素了解甚少。然而,已经证明血清能提供促进非锚定依赖性生长的因子。我们检测了58份肿瘤标本,这些标本取自肺癌、结肠癌、卵巢癌患者或鳞状细胞癌患者,观察它们在无血清或补充血清的培养基中在软琼脂中形成集落的能力。细胞无法复制,所检测的激素或生长因子:胰岛素(I)、转铁蛋白(T)、硒(S)、雌二醇(E)、氢化可的松(H)或表皮生长因子(EGF)均不能替代血清。对血清剂量反应曲线的检查表明,生长因子降低了支持非锚定依赖性生长所需的血清浓度。当细胞最初能够生长时,在51次试验中的38次中,添加补充剂和降低血清浓度提高了克隆效率(C.E.)。与对照组相比,添加ITS在21例中的18例提高了C.E.,添加HITES在17例中的15例提高了C.E.,添加EGF在18例中的12例提高了C.E.。只有当血清是限制因素时,ITS和HITES才会增加集落数量。然而,即使血清不是限制因素,EGF也会增加集落数量。补充剂促进生长的能力与肿瘤类型或初始克隆效率无关。然而,在标准条件下无法形成集落的细胞中,只有1/25的细胞在生长因子存在的情况下被诱导形成集落。在这些生长因子存在的情况下